Cargando…

Graves’ disease diagnosed in remnant thyroid after lobectomy for thyroid cancer

BACKGROUND: The coexistence of Graves’ disease with thyroid cancer is well-known and total thyroidectomy is recommended in such cases. However, Graves’ disease might be dormant at the time of surgery and diagnosed after lobectomy for thyroid cancer. METHODS: We assessed the incidence and clinicopath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Meihua, Jang, Ahreum, Kim, Won Gu, Kim, Tae Yong, Kim, Won Bae, Shong, Young Kee, Jeon, Min Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916678/ https://www.ncbi.nlm.nih.gov/pubmed/35275968 http://dx.doi.org/10.1371/journal.pone.0265332

Ejemplares similares

Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort
por: Jin, Meihua, et al.
Publicado: (2023)

Clinical Outcomes after Early and Delayed Radioiodine Remnant Ablation in Patients with Low-Risk Papillary Thyroid Carcinoma: Propensity Score Matching Analysis
por: Ahn, Jonghwa, et al.
Publicado: (2020)

MON-494 Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to the Treatment: Total Thyroidectomy Versus Total Thyroidectomy with Radioactive Iodine Remnant Ablation
por: Ahn, Jonghwa, et al.
Publicado: (2020)

Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
por: Kwon, Hyemi, et al.
Publicado: (2016)

Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
por: Kim, Won Bae, et al.
Publicado: (2020)

Mutation in Genes Encoding Key Functional Groups Additively Increase Mortality in Patients with BRAF(V600E)-Mutant Advanced Papillary Thyroid Carcinoma
por: Song, Eyun, et al.
Publicado: (2021)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
por: Jeon, Min Ji, et al.
Publicado: (2021)

Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma
por: Jeon, Min Ji, et al.
Publicado: (2022)

Clinical Characteristics and Prognosis of Coexisting Thyroid Cancer in Patients with Graves’ Disease: A Retrospective Multicenter Study
por: Yoon, Jee Hee, et al.
Publicado: (2021)

Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy
por: Lee, Yu-Mi, et al.
Publicado: (2019)

Changes in peripheral blood immune cell population in thyroid cancer patients treated with lenvatinib
por: Jin, Meihua, et al.
Publicado: (2023)

Association between thyroid autoimmunity and Helicobacter pylori infection
por: Choi, Yun Mi, et al.
Publicado: (2017)

Current Status and Future Perspectives in Differentiated Thyroid Cancer
por: Kim, Tae Yong, et al.
Publicado: (2014)

Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease
por: Choi, Yun Mi, et al.
Publicado: (2017)

Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010
por: Choi, Yun Mi, et al.
Publicado: (2014)

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas
por: Jin, Meihua, et al.
Publicado: (2021)

Expression of NF2 Modulates the Progression of BRAF(V600E) Mutated Thyroid Cancer Cells
por: You, Mi-Hyeon, et al.
Publicado: (2019)

Erratum: Figure Correction: Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010
por: Choi, Yun Mi, et al.
Publicado: (2015)

Low Prevalence of Somatic TERT Promoter Mutations in Classic Papillary Thyroid Carcinoma
por: Jeon, Min Ji, et al.
Publicado: (2016)

Quality of Life in Patients with Papillary Thyroid Microcarcinoma According to Treatment: Total Thyroidectomy with or without Radioactive Iodine Ablation
por: Ahn, Jonghwa, et al.
Publicado: (2020)

Clinical Outcomes of Differentiated Thyroid Cancer Patients with Local Recurrence or Distant Metastasis Detected in Old Age
por: Han, Ji Min, et al.
Publicado: (2018)

Clinical Outcomes of N1b Papillary Thyroid Cancer Patients Treated with Two Different Doses of Radioiodine Ablation Therapy
por: Jin, Meihua, et al.
Publicado: (2020)

Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression
por: You, Mi-Hyeon, et al.
Publicado: (2021)

Solitary Skin Metastasis of Papillary Thyroid Carcinoma
por: Kwon, Hyemi, et al.
Publicado: (2014)

Modification of the Tumor-Node-Metastasis Staging System for Differentiated Thyroid Carcinoma by Considering Extra-Thyroidal Extension and Lateral Cervical Lymph Node Metastasis
por: Kim, Mijin, et al.
Publicado: (2020)

Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review
por: Jin, Meihua, et al.
Publicado: (2022)

Clinical Implication of World Health Organization Classification in Patients with Follicular Thyroid Carcinoma in South Korea: A Multicenter Cohort Study
por: Jin, Meihua, et al.
Publicado: (2020)

Expression of X-linked Inhibitor of Apoptosis Protein in Neoplastic Thyroid Disorder
por: Yim, Ji Hye, et al.
Publicado: (2011)

Prognostic parameters for recurrence of papillary thyroid microcarcinoma
por: Kim, Tae Yong, et al.
Publicado: (2008)

Thyrotoxic Periodic Paralysis and Polymorphisms of the ADRB2, AR, and GABRA3 Genes in Men with Graves Disease
por: Park, Suyeon, et al.
Publicado: (2016)

Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer
por: Jang, Eun Kyung, et al.
Publicado: (2015)

Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules
por: Kwon, Hyemi, et al.
Publicado: (2016)

The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells
por: Kim, Won Gu, et al.
Publicado: (2014)

SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
por: Jin, Meihua, et al.
Publicado: (2021)

Comparison of Immunohistochemistry and Direct Sanger Sequencing for Detection of the BRAF(V600E) Mutation in Thyroid Neoplasm
por: Oh, Hye-Seon, et al.
Publicado: (2018)

Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma
por: Kwon, Hyemi, et al.
Publicado: (2015)

SUN-622 Graves Disease Triggered by Lobectomy for Thyroid Cancer
por: Woods, Allison, et al.
Publicado: (2019)

Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data
por: Kim, Won Gu, et al.
Publicado: (2014)

Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
por: Jeon, Min Ji, et al.
Publicado: (2016)

Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria
por: Jeon, Min Ji, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i8bl9k2depe6o45uvft68g5c9i